Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-06-21

FDA Approved: DRONABINOL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for dronabinol (Dronabinol) submitted by Ascend Laboratories, LLC. The product is used for chemotherapy-induced nausea a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)